Trexquant Investment’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-23,204
| Closed | -$223K | – | 1403 |
|
|
2022
Q3 | $223K | Sell |
23,204
-9,143
| -28% | -$87.9K | 0.01% | 1151 |
|
|
2022
Q2 | $234K | Sell |
32,347
-7,329
| -18% | -$53K | 0.01% | 1265 |
|
|
2022
Q1 | $512K | Buy |
39,676
+22,272
| +128% | +$287K | 0.02% | 763 |
|
|
2021
Q4 | $278K | Buy |
+17,404
| New | +$278K | 0.02% | 965 |
|
|
2021
Q2 | – | Sell |
-32,947
| Closed | -$481K | – | 1132 |
|
|
2021
Q1 | $481K | Buy |
+32,947
| New | +$481K | 0.04% | 526 |
|
|
2020
Q3 | – | Sell |
-19,152
| Closed | -$342K | – | 1224 |
|
|
2020
Q2 | $342K | Buy |
+19,152
| New | +$342K | 0.02% | 815 |
|
|
2019
Q3 | – | Sell |
-25,213
| Closed | -$557K | – | 887 |
|
|
2019
Q2 | $557K | Buy |
25,213
+3,977
| +19% | +$87.9K | 0.05% | 444 |
|
|
2019
Q1 | $290K | Buy |
+21,236
| New | +$290K | 0.02% | 758 |
|
|
2018
Q4 | – | Sell |
-71,266
| Closed | -$1.18M | – | 1058 |
|
|
2018
Q3 | $1.18M | Buy |
71,266
+59,016
| +482% | +$974K | 0.09% | 315 |
|
|
2018
Q2 | $172K | Sell |
12,250
-23,002
| -65% | -$323K | 0.01% | 806 |
|
|
2018
Q1 | $390K | Buy |
+35,252
| New | +$390K | 0.03% | 716 |
|
|
2017
Q2 | – | Sell |
-15,061
| Closed | -$319K | – | 825 |
|
|
2017
Q1 | $319K | Buy |
+15,061
| New | +$319K | 0.04% | 727 |
|
|
2016
Q4 | – | Sell |
-21,421
| Closed | -$574K | – | 970 |
|
|
2016
Q3 | $574K | Buy |
21,421
+1,382
| +7% | +$37K | 0.13% | 268 |
|
|
2016
Q2 | $338K | Buy |
+20,039
| New | +$338K | 0.04% | 626 |
|
|
2015
Q4 | – | Sell |
-38,400
| Closed | -$769K | – | 1039 |
|
|
2015
Q3 | $769K | Buy |
+38,400
| New | +$769K | 0.07% | 536 |
|